They are pathetic, aren't they? Even on the harshest days, you can find them huddled in the doorways of every office building in America, sucking in those sweet and deadly toxins. What do you say to people who engage in this relentless act of self-destruction?
Thank you--that is, if you're a tobacco company or an investor in one. Two years after absorbing what was supposed to be a death blow, the industry seems once again as healthy as a vegan marathoner. And last week it got an unexpected pick-me-up from the Bush Justice Department. The DOJ said it may be willing to settle a Clinton-era suit seeking to recoup more than $20 billion in health-care costs. The feds essentially admitted that their case is weak, a view not shared by outraged antismoking advocates, who see the shift as a gift to the industry, which contributed $7 million to the Republican Party.
Not that Big Tobacco needed the generosity. Consider the fortunes of global leader Philip Morris. The firm was the Dow's best performer last year, rising 91% in a turgid market. Tobacco profits, buoyed by strong domestic growth, reached a record $10.6 billion. No. 2 R.J. Reynolds Tobacco and No. 3 British American Tobacco also saw their sales and profits reach new heights.
To appreciate the industry's alluring economics, consider that 90 small, privately held companies have started up to exploit the low-price market; a few years ago, only 10 such firms existed. "The stars are aligned for tobacco stocks," says Bonnie Herzog, a tobacco analyst with Credit Suisse First Boston. "Everything is working in their favor."
It wasn't supposed to be this way. Starting in the mid-'90s, tobacco makers suffered a string of setbacks, culminating in 1998 when the four largest firms settled with 46 states for $206 billion (over 25 years) to help pay for smoking-related illnesses. Big Tobacco agreed to curb advertising, stop marketing to minors (no more Joe Camel) and fund a national antismoking group to police their practices. In 1999 the Clinton Administration filed its suit. More recently, Philip Morris was assessed $3 billion in damages to a single smoker in California. Throw in price increases of more than 60% that had begun to cut demand, and domestic tobacco seemed doomed.
Today it is clear that none of these threats are terminal. "We put out well-crafted p.r.," says Edward Sweda, a senior attorney with the Tobacco Control Resource Center at Northeastern University. "But the companies are engaged in business as usual."
For starters, Washington is a friendlier town. Attorney General John Ashcroft opposed the Clinton suit when he was a Senator and shows little zeal for prosecuting the industry further. Another round of federal excise taxes, championed by Clinton, is not in the offing. To pre-empt harsher regulations and win protection against future lawsuits, Philip Morris is even asking Congress to grant the FDA limited oversight. Such longtime foes as Illinois Senator Dick Durbin are nonplussed. "It's laughable," he says, referring to the DOJ's settlement talks. "In a real negotiation, they could have included [FDA] regulation with teeth. Now they'll be lucky to get anything."